<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FEF0A749-B120-4F09-B8E8-01CFCDFC0A2F"><gtr:id>FEF0A749-B120-4F09-B8E8-01CFCDFC0A2F</gtr:id><gtr:name>Baylor College of Medicine</gtr:name><gtr:address><gtr:line1>Baylor College of Medicine</gtr:line1><gtr:line2>Texas Medical Center</gtr:line2><gtr:line4>Houston</gtr:line4><gtr:line5>Texas</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4B01BD39-EBAB-4969-801E-A7CC63E8FA1C"><gtr:id>4B01BD39-EBAB-4969-801E-A7CC63E8FA1C</gtr:id><gtr:name>Ontario Institute for Cancer Research</gtr:name><gtr:address><gtr:line1>101 College Street</gtr:line1><gtr:line2>Suite 800</gtr:line2><gtr:postCode>M5G 0A3</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Canada</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/690ECCF2-F290-4AE0-82CC-F5507E8EDC7E"><gtr:id>690ECCF2-F290-4AE0-82CC-F5507E8EDC7E</gtr:id><gtr:name>Agency for Science, Technology and Research (A*STAR)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:department>Institute of Cellular Medicine</gtr:department><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FEF0A749-B120-4F09-B8E8-01CFCDFC0A2F"><gtr:id>FEF0A749-B120-4F09-B8E8-01CFCDFC0A2F</gtr:id><gtr:name>Baylor College of Medicine</gtr:name><gtr:address><gtr:line1>Baylor College of Medicine</gtr:line1><gtr:line2>Texas Medical Center</gtr:line2><gtr:line4>Houston</gtr:line4><gtr:line5>Texas</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4B01BD39-EBAB-4969-801E-A7CC63E8FA1C"><gtr:id>4B01BD39-EBAB-4969-801E-A7CC63E8FA1C</gtr:id><gtr:name>Ontario Institute for Cancer Research</gtr:name><gtr:address><gtr:line1>101 College Street</gtr:line1><gtr:line2>Suite 800</gtr:line2><gtr:postCode>M5G 0A3</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Canada</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/690ECCF2-F290-4AE0-82CC-F5507E8EDC7E"><gtr:id>690ECCF2-F290-4AE0-82CC-F5507E8EDC7E</gtr:id><gtr:name>Agency for Science, Technology and Research (A*STAR)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/8B5F23A3-384A-4523-BF0C-DE018D2E812B"><gtr:id>8B5F23A3-384A-4523-BF0C-DE018D2E812B</gtr:id><gtr:firstName>Venetia</gtr:firstName><gtr:surname>Bigley</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0800358"><gtr:id>C609670A-254F-4074-B583-C9070B7A0C81</gtr:id><gtr:title>Homeostasis of Langerhans and Dendritic Cells in Health and Disease</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0800358</gtr:grantReference><gtr:abstractText>Dendritic cells are critical components of the immune system. They detect foreign material and coordinate the immune response. Without them immunity to viruses, tumours and vaccines is severely compromised. They are important in the rejection of transplanted organs and in ?graft versus host disease?, a complication of bone marrow transplantation. Additionally, they multiply and accumulate in ?histiocytosis?, a rare but potentially fatal disease.

The question we are studying is how these cells are maintained in the body. Previously they were thought to be replaced at a steady rate by cells from the blood. Recent evidence from mice suggests that they can proliferate or renew themselves but this is not known in humans. We propose to find out 1) whether human skin dendritic cells can renew themselves; 2) what controls their survival and proliferation; 3) whether they are affected by bone marrow failure. We will use normal human skin obtained from plastic surgery and small samples from patients with specific bone marrow disorders. Our experiments will help to understand how the immune system is controlled in health and disease, including bone marrow failure and transplantation. We may identify new ways to boost vaccination, prevent harmful immune responses and treat histiocytosis</gtr:abstractText><gtr:technicalSummary>Migratory dendritic cells (DC) are key sentinels of the immune system. How they are maintained in sites of antigen exposure remains an important unresolved question in humans. Recent evidence in murine models has revised the conventional view that DC are continually replaced by bone marrow derived, blood borne precursors and suggests that some level of local self-renewal operates in the steady state. This is especially important in the case of epidermal Langerhans cells (LC). Equivalent data are lacking in humans.

Elucidating the homeostasis of human DC and LC is vital to understanding: (i) the induction of immunity or tolerance; (ii) the paradoxical preservation of adaptive immunity relative to innate defence in bone marrow failure; (iii) the tissue tropism of graft versus host disease, in which persistent proliferative recipient DC may play a key role; (iv) the accumulation of abnormal proliferating DC and LC in histiocytic disorders. Understanding the factors that promote local self-renewal may lead to new therapeutic avenues.

This project will test the hypothesis: Human Langerhans cells and other peripheral myeloid dendritic cells are maintained by local self-renewal in the steady state. 
The following experimental questions will be tackled:

1. Do LC and DC synthesize DNA and proliferate in situ?

2. What controls the survival and proliferation of LC and DC ex vivo?

3. Does abnormal myelopoiesis interfere with LC and DC homeostasis?

Preliminary DNA content analysis on normal skin obtained from plastic surgery suggests that 2-3% of LC and up to 4% of dermal DC are cycling. I will further investigate this finding by testing ki-67 antigen expression, DNA synthesis (BrdU incorporation) and LC and DC stability in skin explant culture. I will then develop simple in vitro survival and DNA synthesis assays to investigate the effect of growth factors such as M-CSF, GM-CSF and flt-3L that have been identified as important to DC homeostasis in murine systems. I will also use a commercial library of kinase inhibitors as a screening tool to uncover new survival pathways for peripheral LC and DC in humans. Finally, I will use small cohorts of patients with failing or cytogenetically abnormal myelopoiesis to determine whether peripheral DC populations are depleted or contain translocations, respectively. This constitutes a unique in vivo test of the hypothesis and is directly relevant to understanding host defence in bone marrow failure syndromes.</gtr:technicalSummary><gtr:fund><gtr:end>2010-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>144512</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Baylor College of Medicine</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Pediatrics</gtr:department><gtr:description>Langerin DC, Houston</gtr:description><gtr:id>979792EC-B32D-463E-83A9-C555A278F80F</gtr:id><gtr:impact>Manuscript in preparation</gtr:impact><gtr:outcomeId>deS4x5EkJYN-1</gtr:outcomeId><gtr:partnerContribution>Intellectual input and provision of research material</gtr:partnerContribution><gtr:piContribution>Analysis of research material, authorship of manuscript</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Agency for Science, Technology and Research (A*STAR)</gtr:collaboratingOrganisation><gtr:country>Singapore, Republic of</gtr:country><gtr:description>Langerin DC and DC deficiency, Singapore</gtr:description><gtr:id>81626827-7342-49E5-AF6C-1983A2C4676C</gtr:id><gtr:impact>Manuscript in preparation</gtr:impact><gtr:outcomeId>YYW9Xqtxfod-1</gtr:outcomeId><gtr:partnerContribution>Interlectual</gtr:partnerContribution><gtr:piContribution>Analysis of human material in comparison with Singapore mouse work</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ontario Institute for Cancer Research (OICR)</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:description>John Dick lab, Toronto</gtr:description><gtr:id>7F627449-ADC7-4633-BA34-22D3A0E2651F</gtr:id><gtr:impact>Manuscript submitted to JEM</gtr:impact><gtr:outcomeId>qpqxVkwsEJB-1</gtr:outcomeId><gtr:partnerContribution>Technical (provision of protocol) and intellectual</gtr:partnerContribution><gtr:piContribution>Identification and phenotypic description of human phenotype supporting in vitro and mouse model of dendritic cell ontogeny.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Newspaper article</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>178BC18E-1D0B-4A26-AACF-2EC4A026F83B</gtr:id><gtr:impact>Newspaper articles:
1. The Telegraph 17th Feb 2011 'Doctors save life of young mother with mystery illness'
2. Daily Mail 18th Feb 2011 'Doctors save dying mother from new disease after making world-first diagnosis'

Referral of other patients for diagnostic testing and profiling of dendritic cell subsets for research.</gtr:impact><gtr:outcomeId>snMzfKFCqcF</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>101472</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>British Society for Haematology `Early-stage Investigator start-up award'</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>British Society for Haematology (BSH)</gtr:fundingOrg><gtr:id>E2E956EE-9784-441C-8975-E16A4A99C2E0</gtr:id><gtr:outcomeId>hk5xXs8UsDJ0</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2011-08-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Identification of a syndrome of monocyte and DC deficiency in humans, and treatment with stem cell transplant</gtr:description><gtr:id>F5ABB879-1D88-4132-BC9F-2C35A64114C8</gtr:id><gtr:impact>Successful treatment of 2 patients</gtr:impact><gtr:outcomeId>R21JCfg13ja</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>DC deficiency</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Fast Technique to diagnose LCH by flow cytometric analysis of lesional material</gtr:description><gtr:id>22A7273A-C7FA-447E-9508-9E5220512853</gtr:id><gtr:impact>Faster treatment initiation for LCH patients</gtr:impact><gtr:outcomeId>FdJktjqA9ir</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Langerhans Cell Histiocytosis Diagnosis</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>A135B38A-8F38-4A19-86A3-C03858FD5F57</gtr:id><gtr:title>Dendritic cell, monocyte, B and NK lymphoid deficiency defines the lost lineages of a new GATA-2 dependent myelodysplastic syndrome.</gtr:title><gtr:parentPublicationTitle>Haematologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba0d5bcbc9af11be137705c5f84d8e19"><gtr:id>ba0d5bcbc9af11be137705c5f84d8e19</gtr:id><gtr:otherNames>Bigley V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0390-6078</gtr:issn><gtr:outcomeId>HPABmT7HACS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59117DF4-D3AF-4E2A-8F90-D040A79109DC</gtr:id><gtr:title>Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f665fcdbf37a51567b3080a9eaa06de2"><gtr:id>f665fcdbf37a51567b3080a9eaa06de2</gtr:id><gtr:otherNames>Haniffa M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn><gtr:outcomeId>pm_15812_22_22795876</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D96250D6-4517-49A7-AF55-64703660DDC2</gtr:id><gtr:title>The evolution of cellular deficiency in GATA2 mutation.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c28551404bc2b202da3d3e5fda1bb112"><gtr:id>c28551404bc2b202da3d3e5fda1bb112</gtr:id><gtr:otherNames>Dickinson RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>545762a9794611.89797645</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06BDF23B-4C7B-4932-8461-4869BEF71C86</gtr:id><gtr:title>Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c28551404bc2b202da3d3e5fda1bb112"><gtr:id>c28551404bc2b202da3d3e5fda1bb112</gtr:id><gtr:otherNames>Dickinson RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>kj9heLBhHVx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8DA2E63-96A4-40A0-AC20-B6740FBD79AB</gtr:id><gtr:title>The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba0d5bcbc9af11be137705c5f84d8e19"><gtr:id>ba0d5bcbc9af11be137705c5f84d8e19</gtr:id><gtr:otherNames>Bigley V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>Cn2RTGkcXcS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E1499045-2BE3-495D-B401-E75337A180A2</gtr:id><gtr:title>Evolution of Dendritic Cell, Monocyte B and NK Lymphoid (DCML) deficiency; a human primary immunodeficiency arising from GATA-2 mutation</gtr:title><gtr:parentPublicationTitle>IMMUNOLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa74c961788b40478f6f1c2d503707a5"><gtr:id>aa74c961788b40478f6f1c2d503707a5</gtr:id><gtr:otherNames>Collin M.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>dC9dxpt1X3x</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C566647-499C-4801-839C-89A6CEE839F6</gtr:id><gtr:title>Cell(s) of Origin of Langerhans Cell Histiocytosis.</gtr:title><gtr:parentPublicationTitle>Hematology/oncology clinics of North America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36f723085061eb97252599069a288e02"><gtr:id>36f723085061eb97252599069a288e02</gtr:id><gtr:otherNames>Collin M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0889-8588</gtr:issn><gtr:outcomeId>56df72964b50d1.85807086</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D40D917-A9CC-4C97-A231-F241EACAEAE8</gtr:id><gtr:title>Langerin-expressing dendritic cells in human tissues are related to CD1c+ dendritic cells and distinct from Langerhans cells and CD141high XCR1+ dendritic cells.</gtr:title><gtr:parentPublicationTitle>Journal of leukocyte biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba0d5bcbc9af11be137705c5f84d8e19"><gtr:id>ba0d5bcbc9af11be137705c5f84d8e19</gtr:id><gtr:otherNames>Bigley V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0741-5400</gtr:issn><gtr:outcomeId>56df7296226113.13895173</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36BF3E53-512C-4E8F-8E47-9DD91418C56F</gtr:id><gtr:title>Human dendritic cell deficiency: the missing ID?</gtr:title><gtr:parentPublicationTitle>Nature reviews. Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36f723085061eb97252599069a288e02"><gtr:id>36f723085061eb97252599069a288e02</gtr:id><gtr:otherNames>Collin M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1474-1733</gtr:issn><gtr:outcomeId>n4buHFMtp8k</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>490E15E6-4CA3-4F85-9002-227D53C11889</gtr:id><gtr:title>IRF8 mutations and human dendritic-cell immunodeficiency.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7989442453d65a58f1c58844b72a92f9"><gtr:id>7989442453d65a58f1c58844b72a92f9</gtr:id><gtr:otherNames>Hambleton S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>KjwMtMsq1xt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AFB7F727-ADAC-49AF-A462-24BE2565482B</gtr:id><gtr:title>Dendritic cell, monocyte, B and NK lymphoid deficiency: a novel but potentially fatal haematological disorder curable with haematopoietic stem cell transplantation</gtr:title><gtr:parentPublicationTitle>BONE MARROW TRANSPLANTATION</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/305d579a96a2dbadb5ffeacb6d0cb413"><gtr:id>305d579a96a2dbadb5ffeacb6d0cb413</gtr:id><gtr:otherNames>Bigley V.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0268-3369</gtr:issn><gtr:outcomeId>nEY2hcUWCU2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2CF9BE3C-2DA1-4C03-9890-44BC21B70628</gtr:id><gtr:title>CD1c+ blood dendritic cells have Langerhans cell potential.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fd5dd16f28274faafa047ea8d2ab44b"><gtr:id>2fd5dd16f28274faafa047ea8d2ab44b</gtr:id><gtr:otherNames>Milne P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>56df729667c816.26175116</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FBBF5963-18E7-4DE4-91EC-710AE748183E</gtr:id><gtr:title>HUMAN DENDRITIC CELL DEFICIENCY</gtr:title><gtr:parentPublicationTitle>JOURNAL OF CLINICAL IMMUNOLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/305d579a96a2dbadb5ffeacb6d0cb413"><gtr:id>305d579a96a2dbadb5ffeacb6d0cb413</gtr:id><gtr:otherNames>Bigley V.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0271-9142</gtr:issn><gtr:outcomeId>XkjE9s1i8h3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B308203D-1904-4659-A7D6-FD86D4AA2B91</gtr:id><gtr:title>Connecting the dots: monocyte/DC and NK subsets in human peripheral blood.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba0d5bcbc9af11be137705c5f84d8e19"><gtr:id>ba0d5bcbc9af11be137705c5f84d8e19</gtr:id><gtr:otherNames>Bigley V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>d8dqecJd3wd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93DB4767-D190-48E2-B811-74A281AC3CA7</gtr:id><gtr:title>Rapid detection of dendritic cell and monocyte disorders using CD4 as a lineage marker of the human peripheral blood antigen-presenting cell compartment.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e07a08641192317e967476be1e968105"><gtr:id>e07a08641192317e967476be1e968105</gtr:id><gtr:otherNames>Jardine L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>545762e673c9f7.18217403</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>72D066CC-7F96-4720-AB29-F1C342582187</gtr:id><gtr:title>Tumor necrosis factor-costimulated T lymphocytes from patients with systemic sclerosis trigger collagen production in fibroblasts.</gtr:title><gtr:parentPublicationTitle>Arthritis and rheumatism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/48546b9db7ba3312b748caa2e685cf93"><gtr:id>48546b9db7ba3312b748caa2e685cf93</gtr:id><gtr:otherNames>H?gle T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0004-3591</gtr:issn><gtr:outcomeId>doi_15812__art_37738</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E293573-5413-4F2E-924F-3BACB57AEDA4</gtr:id><gtr:title>A comparative study of reduced dose alemtuzumab in matched unrelated donor and related donor reduced intensity transplants.</gtr:title><gtr:parentPublicationTitle>British journal of haematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e07a08641192317e967476be1e968105"><gtr:id>e07a08641192317e967476be1e968105</gtr:id><gtr:otherNames>Jardine L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0007-1048</gtr:issn><gtr:outcomeId>56df7296e8e365.29488182</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0800358</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>